TI
BCAX

Trexquant Investment’s Bicara Therapeutics BCAX Stock Holding History

Trexquant Investment’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
+59,220
New +$1.32M 0.01% 1256
2026
Q1 		– Sell
-37,094
Closed -$624K – 2109
2025
Q4 		$624K Sell
37,094
-919
-2% -$15.7K 0.01% 1296
2025
Q3 		$600K Sell
38,013
-12,483
-25% -$140K 0.01% 1281
2025
Q2 		$469K Buy
+50,496
New +$602K 0.01% 1279

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trexquant Investment's BCAX Position: Q2 2026 in Review

Trexquant Investment opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 59,220 shares worth $1.76M. The stake represents 0.01% of the portfolio and ranks #1256 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in BCAX as recently as Q4 2025.

Trexquant Investment first reported a position in BCAX in Q2 2025 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Trexquant Investment held 59,220 shares of Bicara Therapeutics worth $1.76M as of Q2 2026.
  • Bicara Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Bicara Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1256 holding.
  • Trexquant Investment first reported a position in Bicara Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.